Opeskin K - Search Results

1

A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.

Holloway AJ, Diyagama DS, Opeskin K, Creaney J, Robinson BW, Lake RA, Bowtell DD. Holloway AJ, et al. Among authors: opeskin k. Clin Cancer Res. 2006 Sep 1;12(17):5129-35. doi: 10.1158/1078-0432.CCR-06-1027. Clin Cancer Res. 2006. PMID: 16951230

2

Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.

Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL, Williams ED. Zeng Y, et al. Among authors: opeskin k. Clin Cancer Res. 2004 Aug 1;10(15):5137-44. doi: 10.1158/1078-0432.CCR-03-0434. Clin Cancer Res. 2004. PMID: 15297417

3

Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer.

Newnham GM, Conron M, McLachlan S, Dobrovic A, Do H, Li J, Opeskin K, Thompson N, Wright GM, Thomas DM. Newnham GM, et al. Among authors: opeskin k. BMC Cancer. 2011 Mar 7;11:93. doi: 10.1186/1471-2407-11-93. BMC Cancer. 2011. PMID: 21385341 Free PMC article.

4

Copy number analysis of ductal carcinoma in situ with and without recurrence.

Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, Mann GB, Campbell IG. Gorringe KL, et al. Among authors: opeskin k. Mod Pathol. 2015 Sep;28(9):1174-84. doi: 10.1038/modpathol.2015.75. Epub 2015 Jun 19. Mod Pathol. 2015. PMID: 26321097 Free article.

5

Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.

Zeng Y, Opeskin K, Goad J, Williams ED. Zeng Y, et al. Among authors: opeskin k. Cancer Res. 2006 Oct 1;66(19):9566-75. doi: 10.1158/0008-5472.CAN-06-1488. Cancer Res. 2006. PMID: 17018613

6

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma.

Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG. Johnson CE, et al. Among authors: opeskin k. Breast Cancer Res Treat. 2012 Jun;133(3):889-98. doi: 10.1007/s10549-011-1835-1. Epub 2011 Nov 4. Breast Cancer Res Treat. 2012. PMID: 22052326 Free article.

7

No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.

Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG. Qiu W, et al. Among authors: opeskin k. Nat Genet. 2008 May;40(5):650-5. doi: 10.1038/ng.117. Epub 2008 Apr 13. Nat Genet. 2008. PMID: 18408720 Free PMC article.

8

Lymphatic vessel density and lymph node metastasis in prostate cancer.

Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED. Zeng Y, et al. Among authors: opeskin k. Prostate. 2005 Nov 1;65(3):222-30. doi: 10.1002/pros.20288. Prostate. 2005. PMID: 15948136

9

Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.

Coso S, Zeng Y, Opeskin K, Williams ED. Coso S, et al. Among authors: opeskin k. PLoS One. 2012;7(6):e39558. doi: 10.1371/journal.pone.0039558. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22745786 Free PMC article.

10

BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.

McCulloch DR, Opeskin K, Thompson EW, Williams ED. McCulloch DR, et al. Among authors: opeskin k. Prostate. 2005 Sep 15;65(1):35-43. doi: 10.1002/pros.20255. Prostate. 2005. PMID: 15800936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters